European Archives - Page 584 of 1638 - European Medical Journal

Peritoneal Tuberculosis in the Guise of Ovarian Carcinoma

Peritoneal tuberculosis (TB) is a form of extrapulmonary TB that primarily affects areas such as the omentum, liver…

Can Time-Restricted Feeding Improve MAFLD Management?

Time-restricted feeding (TRF), limits food intake to a set daily window, such as the 16:8 model.

The World’s First Autonomous AI Skin Cancer Detector Approved for Use in Europe

World-first AI for skin cancer detection approved in Europe, cutting wait times and outperforming dermatologists with 99.8% accuracy.

Tackling bias, driving change: a roundtable for International Women’s Day

How can the pharmaceutical industry ‘Accelerate Action’ on gender parity this International Women’s Day? Find out now.

Obesity Hampers Gout Therapy Success, Raising Gout Flare Risks

Obesity significantly diminishes the effectiveness of urate-lowering therapy in male gout patients, according to a new study. Only 38.9% of obese patients achieved target serum urate levels compared to 63.8% of normal-weight patients, highlighting the need for integrated weight management in gout treatment.

EMJ Reproductive Health 11 [Supplement 1] 2025

Expand your understanding of cardiovascular (CV) health in women experiencing menopause, and stay ahead of developments in women’s…

Cardiovascular health in menopause

A distinguished panel of experts elaborated on different aspects of cardiovascular health in women receiving menopausal hormone therapy…

Study Finds No Overall Association Between Hormone Therapy and Glioma

A new study suggests that hormone therapy (HT) does not significantly increase the risk of glioma in postmenopausal women, except for a potential elevated risk in women with higher education. Researchers call for further investigation into these subgroup differences.

Tuberculosis Vaccine Trial Shows No Protection Against Recurrence

A Phase IIb clinical trial evaluating the tuberculosis vaccine H56:IC31 has found no evidence that it reduces the risk of recurrent disease in individuals who have completed treatment for pulmonary tuberculosis.

Xavier Leleu

Hema Now: Episode 12: Breaking Boundaries in Multiple Myeloma Research

Xavier Leleu, Head of the Department of Hematology at Centre Hospitalier Universitaire (CHU), Université de Poitiers, France